Telemedicine support for older cancer patients in underserved communities
Geriatric Assessment (GA)-Driven Interventions With Supportive Care (The GAIN-S Trial): Telemedicine to Increase Goal Concordant Care for Older Adults With Cancer in the Community
This study tests whether using telemedicine to provide extra support can help older cancer patients in underserved communities feel better and have fewer hospital visits compared to standard care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 216 (estimated) |
| Ages | 65 Years and up |
| Sex | All |
| Sponsor | City of Hope Medical Center Academic / other |
| Drugs / interventions | chemotherapy, immunotherapy |
| Locations | 3 sites (Duarte, California and 2 other locations) |
| Trial ID | NCT06022965 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of geriatric assessment-driven interventions using telemedicine to support older adults with cancer in underserved communities. The GAIN-S approach aims to identify vulnerabilities in patients and enhance communication between healthcare providers and caregivers. Participants will be randomized into two groups: one receiving telemedicine-based supportive care and the other receiving standard care. The study will assess outcomes such as treatment toxicity, hospitalizations, and patient satisfaction over a six-month period.
Who should consider this trial
Good fit: Ideal candidates for this study are older adults aged 65 and above who have been diagnosed with stage I-IV cancer and are scheduled to start a new therapy.
Not a fit: Patients who are unable to comply with study procedures or have significant logistical issues may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the quality of care and treatment outcomes for older cancer patients in underserved areas.
How similar studies have performed: Other studies have shown promise in using telemedicine for geriatric care, but this specific approach is novel in its focus on cancer care for older adults in underserved communities.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Documented informed consent of the participant. * Patient's physician must agree for patient participation. * Ability to read English, Spanish, or Chinese. Other languages will be acceptable with site principal investigator (PI) agreement if surveys are available, and language does not preclude completing study procedures. * Age: \>=65 years at the time of enrollment. * Diagnosis of stage I-IV cancer. * Scheduled to start a new therapy (chemotherapy, immunotherapy, or targeted therapy). Exclusion Criteria: * Prospective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics).
Where this trial is running
Duarte, California and 2 other locations
- City of Hope Medical Center — Duarte, California, United States (Recruiting)
- City of Hope Antelope Valley — Lancaster, California, United States (Recruiting)
- City of Hope Upland — Upland, California, United States (Recruiting)
Study contacts
- Principal investigator: William Dale — City of Hope Medical Center
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.